guess they will need alot more prefilled syringes soon
Sanofi-Aventis now owns 100% of Merial, shareholder approved a day ago. IMU owns worldwide rights to technology which will secure IMU 5-6% royalties on sales in a $3bn market. IMU's leading vaccines especially PRSS are on the threshold of commercialisation
ref link
http://en.sanofi-aventis.com/binaries/20090730_merial_deal_en_tcm28-25800.pdf
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$8.74 |
Change
0.260(3.07%) |
Mkt cap ! $670.5M | |||
| Open | High | Low | Value | Volume |
| $8.50 | $8.91 | $8.45 | $31.74M | 3.633M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 77 | $8.74 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $8.85 | 22173 | 1 |
View Market Depth
| Last trade - 16.10pm 19/09/2025 (20 minute delay) ? |
| UNI (ASX) Chart |